One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news / March 2017

Archive

✕

9 March 2017

3450

Patient-generated Health Data: Unlocking The Value

Patient-generated Health Data: Unlocking The Value

"We've killed more people because we didn't share data than because we did," as one of the memorable quotes were among my many takeaways from the Healthcare Information and Management Systems Society (HIMSS) annual conference last week in Orlando. A continuing concern in ...

9 March 2017

3480

Are Statins in Current Use Reduces Risk Of HIV Rebound On Suppressive HAART?

Are Statins in Current Use Reduces Risk Of HIV Rebound On Suppressive HAART?

Statin exposure was associated with reduced risk of virological failure based on 19,324 HIV-infected US-Veterans who started HAART 1995–2011 study says. Statins besides their lowering cholesterol effects are also known for such functions as improvement of endothelial dysfunction, ...

9 March 2017

3462

10 of 16 HIV Patients Still Undetectable After Weekly Injections of Antibody PRO 140

10 of 16 HIV Patients Still Undetectable After Weekly Injections of Antibody PRO 140

Self-injected monotherapy with a monoclonal antibody that binds to the CCR5 chemokine receptor on CD4 immune T-cells maintained viral suppression in 10 of 16 study participants for 41 to 123 weeks. Five participants experienced virologic failure, and one person dropped out ...

7 March 2017

3781

A Compulsory Licence For Raltegravir To Be Issued In Germany

A Compulsory Licence For Raltegravir To Be Issued In Germany

The first time in the 55-year history of the Federal Patent Court ('Bundespatentgericht') that a compulsory licence has been granted in proceedings Bird & Bird says. Shionogi, a patentee of the European Patent EP 1 422 218, which covers the antiviral compound Raltegravir ...

7 March 2017

3320

We Need A Cancer Moonshot But Applied To HIV

We Need A Cancer Moonshot But Applied To HIV

Cellular therapy tools range from gene transfer technologies, such as lentiviral vectors and RNA engineering, to the more recent precision genome editing systems, such as TALENs and CRISPR/Cas9 nucleases. Dr Carl H. June, the director of the Center for Immunotherapy at ...

7 March 2017

4757

Disclosing HIV Status To Your Sex Buddy Became Simple With This Blockchain Service

Disclosing HIV Status To Your Sex Buddy Became Simple With This Blockchain Service

English geeks made disclosing HIV status before sexual intercourse simple with innovative online service using modern 'blockchain' technology. An update to DoNotPay — a Facebook chatbot that assisted 250,000 people in challenging parking fines, and has since been combined ...

6 March 2017

3650

Patient With HIV After Bone Marrow Transplant Off ART For 288 Days Without Rebound

Patient With HIV After Bone Marrow Transplant Off ART For 288 Days Without Rebound

A viral remission in a bone marrow transplant HIV-positive recipient lasting nearly one year. Such a timeframe is longer than in the so-called Boston patients. This case presented by Nathan Cummins of the Mayo Clinic in Rochester, Minnesota, and colleagues at the Conference ...

6 March 2017

3538

People Living With HIV Tend To Suppress The Virus Below 1,500 In The U. S.

People Living With HIV Tend To Suppress The Virus Below 1,500 In The U. S.

The viral load above 1,500 represents the point above which the HIV is considered significantly infectious since there have been few documented cases of transmission from people with viral loads below that level. This indicator is interesting because it is possible to estimate ...

6 March 2017

3785

HIV Young Leaders Fund Small Grants Programme Proposals. Last Call! Ends on March 10th 2017.

HIV Young Leaders Fund Small Grants Programme Proposals. Last Call! Ends on March 10th 2017.

You might be interested in applying for an HIV Young Leaders grant which supports organizations and projects led by and serving young key populations affected by HIV, with limited access to funding opportunities and working within countries and regions with diverse structural ...

6 March 2017

3884

New Drug Lead From Soil Bacteria Compound Identified To Fight Against Tuberculosis

New Drug Lead From Soil Bacteria Compound Identified To Fight Against Tuberculosis

The study's findings lead the way to a treatment for tuberculosis (TB). Deemed by many to be a relic of past ages, TB still causes more deaths than any other infectious disease among HIV-positive people. A collaboration of researchers, including the University of Warwick ...

1...3 4 5 6